Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Melanoma treatment costs: a systematic review of the literature, 1990-2011.

Guy GP Jr, Ekwueme DU, Tangka FK, Richardson LC.

Am J Prev Med. 2012 Nov;43(5):537-45. doi: 10.1016/j.amepre.2012.07.031. Review.

2.

An estimate of the annual direct cost of treating cutaneous melanoma.

Tsao H, Rogers GS, Sober AJ.

J Am Acad Dermatol. 1998 May;38(5 Pt 1):669-80.

PMID:
9591809
3.
4.

Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.

Seidler AM, Pennie ML, Veledar E, Culler SD, Chen SC.

Arch Dermatol. 2010 Mar;146(3):249-56. doi: 10.1001/archdermatol.2009.389.

PMID:
20231494
5.

Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature.

Guy GP, Ekwueme DU.

Pharmacoeconomics. 2011 Oct;29(10):863-74. doi: 10.2165/11589300-000000000-00000. Review.

PMID:
21846158
6.

Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review.

Gordon LG, Rowell D.

Eur J Cancer Prev. 2015 Mar;24(2):141-9. doi: 10.1097/CEJ.0000000000000056. Review.

PMID:
25089375
7.

Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).

Johnston K, Levy AR, Lorigan P, Maio M, Lebbe C, Middleton M, Testori A, Bédane C, Konto C, Dueymes A, Sbarigia U, van Baardewijk M.

Eur J Cancer. 2012 Sep;48(14):2175-82. doi: 10.1016/j.ejca.2012.03.003. Epub 2012 Apr 3.

PMID:
22480965
8.

Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.

Davis KL, Mitra D, Kotapati S, Ibrahim R, Wolchok JD.

Appl Health Econ Health Policy. 2009;7(1):31-41. doi: 10.2165/00148365-200907010-00004.

PMID:
19558193
9.

Stage-specific direct health care costs in patients with cutaneous malignant melanoma.

Lyth J, Carstensen J, Synnerstad I, Lindholm C.

J Eur Acad Dermatol Venereol. 2016 May;30(5):789-93. doi: 10.1111/jdv.13110. Epub 2015 Mar 23.

PMID:
25807966
10.

The economic burden of melanoma in France: assessing healthcare use in a hospital setting.

Chevalier J, Bonastre J, Avril MF.

Melanoma Res. 2008 Feb;18(1):40-6. doi: 10.1097/CMR.0b013e3282f36203.

PMID:
18227707
11.

An estimate of the cost of treating non-melanoma skin cancer in the state of São Paulo, Brazil.

Souza RJ, Mattedi AP, Corrêa MP, Rezende ML, Ferreira AC.

An Bras Dermatol. 2011 Jul-Aug;86(4):657-62. English, Portuguese.

12.

A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation.

Nellesen D, Yee K, Chawla A, Lewis BE, Carson RT.

J Manag Care Pharm. 2013 Nov-Dec;19(9):755-64. Review.

13.

An estimate of the cost of treating melanoma disease in the state of Sao Paulo - Brazil.

Souza RJ, Mattedi AP, Rezende ML, Corrêa Mde P, Duarte EM.

An Bras Dermatol. 2009 Jul;84(3):237-43. English, Portuguese.

14.

The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006.

Ekwueme DU, Guy GP Jr, Li C, Rim SH, Parelkar P, Chen SC.

J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S133-43. doi: 10.1016/j.jaad.2011.04.036.

15.

Costs of illness for melanoma and nonmelanoma skin cancer in Denmark.

Bentzen J, Kjellberg J, Thorgaard C, Engholm G, Phillip A, Storm HH.

Eur J Cancer Prev. 2013 Nov;22(6):569-76. doi: 10.1097/CEJ.0b013e328360150c.

PMID:
23542376
16.

Estimating healthcare resource use associated with the treatment of metastatic melanoma in eight countries.

McKendrick J, Gijsen M, Quinn C, Barber B, Zhao Z.

J Med Econ. 2016 Jun;19(6):587-95. doi: 10.3111/13696998.2016.1148043. Epub 2016 Feb 10.

PMID:
26823114
17.

[Descriptive study of the costs of diagnosis and treatment of cutaneous melanoma].

Almazán-Fernández FM, Serrano-Ortega S, Moreno-Villalonga JJ.

Actas Dermosifiliogr. 2009 Nov;100(9):785-91. Spanish. Erratum in: Actas Dermosifiliogr. 2009 Dec;100(10):894.

PMID:
19889300
18.

Cost-Effectiveness of Skin Surveillance Through a Specialized Clinic for Patients at High Risk of Melanoma.

Watts CG, Cust AE, Menzies SW, Mann GJ, Morton RL.

J Clin Oncol. 2017 Jan;35(1):63-71. Epub 2016 Oct 28.

PMID:
28034073
19.

Investment in new technology research can save future health care dollars.

Reintgen D, Albertini J, Milliotes G, Marshburn J, Cruse CW, Rapaport D, Berman C, Glass F, Fensske N, Einstein AB Jr, Lyman G.

J Fla Med Assoc. 1997 Mar;84(3):175-81.

PMID:
9143169
20.

Estimating the economic costs of skin cancer in New South Wales, Australia.

Doran CM, Ling R, Byrnes J, Crane M, Searles A, Perez D, Shakeshaft A.

BMC Public Health. 2015 Sep 23;15:952. doi: 10.1186/s12889-015-2267-3.

Supplemental Content

Support Center